Sana Biotechnology Inc

Healthcare · Biotechnology · —

2.70$ -1.1% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Sana Biotechnology Inc (SANA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 432 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SANA
Line item	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	415	–	–	768	730	1,304	1,260	1,233	1,129	1,048	971	898	823	747	707	631	565	681	619	559	501	445	362	435	417	374	432
Current Assets	144	139	–	456	384	967	860	613	558	523	494	500	444	370	339	280	214	321	263	210	161	113	83	162	149	112	171
Cash	80	-139	–	149	125	751	675	434	253	189	195	163	177	160	174	168	134	177	135	127	128	96	71	103	72	84	57
Cash & Short-Term Investments	139	139	–	451	378	960	853	604	551	512	485	486	424	349	326	269	205	311	252	199	152	105	73	153	138	101	160
Property, Plant & Equipment	69	–	–	–	110	113	119	63	65	69	68	67	67	64	157	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	141	–	–	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141	141
Intangible Assets	59	–	–	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59	59
Total Liabilities	558	–	–	1,079	1,151	422	354	403	401	346	332	332	323	319	352	266	278	306	279	267	251	236	239	240	256	254	277
Current Liabilities	19	–	–	27	31	35	43	92	99	94	97	115	112	103	112	67	64	53	51	47	45	33	33	36	79	86	124
Short-Term Debt	1.3	–	–	3.2	3.7	3.9	6.0	6.5	9.2	9.6	11	12	12	13	13	13	13	13	10.0	11	13	13	14	15	15	15	15
Accounts Payable	0.0	–	–	3.9	2.3	4.3	3.7	3.9	2.2	4.8	3.1	4.0	2.9	2.3	3.1	9.9	4.1	6.1	3.8	3.0	5.2	1.0	2.3	1.9	1.7	2.1	1.4
Shareholders' Equity	-143	275	–	-311	-421	882	906	830	729	702	640	566	499	428	355	366	288	375	340	292	251	209	123	195	161	119	155
Retained Earnings	-144	–	–	-316	-429	-610	-591	-675	-785	-817	-889	-974	-1,055	-1,137	-1,251	-1,250	-1,338	-1,446	-1,496	-1,556	-1,605	-1,654	-1,748	-1,790	-1,849	-1,896	-1,960
Shares Outstanding	159	130	130	130	175	183	191	182	184	186	188	189	190	191	193	200	197	217	234	235	236	238	238	260	253	277	296

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings